In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Spinal Concepts completes $21mm Series E financing

Executive Summary

Spinal Concepts Inc. (spinal implant products) raised $21mm through the sale of Series E preferred stock. The financing was co-led by Richland Ventures and HLM Management Co. Other investors included KBL Healthcare Ventures, Essex Woodlands Health Ventures, Olivhan Investments, and return investors Vector Management Fund and Onset Ventures.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies